Is Genetic Mobilization Considered When Using Bacteriophages in Antimicrobial Therapy?
Lorena Rodríguez-RubioJoan JofreMaite MuniesaPublished in: Antibiotics (Basel, Switzerland) (2017)
The emergence of multi-drug resistant bacteria has undermined our capacity to control bacterial infectious diseases. Measures needed to tackle this problem include controlling the spread of antibiotic resistance, designing new antibiotics, and encouraging the use of alternative therapies. Phage therapy seems to be a feasible alternative to antibiotics, although there are still some concerns and legal issues to overcome before it can be implemented on a large scale. Here we highlight some of those concerns, especially those related to the ability of bacteriophages to transport bacterial DNA and, in particular, antibiotic resistance genes.
Keyphrases
- drug resistant
- infectious diseases
- antibiotic resistance genes
- multidrug resistant
- acinetobacter baumannii
- wastewater treatment
- microbial community
- staphylococcus aureus
- pseudomonas aeruginosa
- circulating tumor
- stem cells
- cystic fibrosis
- cell free
- gene expression
- mesenchymal stem cells
- copy number
- cell therapy
- dna methylation